Abbott Labs: Annual EPS in line with expectations
(CercleFinance.com) - Abbott Laboratories reports Q4 2024 adjusted EPS in line with expectations at $1.
34, bringing its YTD figure to $4.67, in line with its target range of three months ago ($4.64-4.70).
The healthcare group reported revenues of $11bn in the last quarter (+10.1% organic on an underlying basis), for a total of $42bn for the year, up 9.6% on an adjusted basis (against a target range of 9.5%-10%).
For the year ahead, Abbott Labs expects adjusted EPS of $5.05 to $5.25, a non-GAAP operating margin of 23.5% to 24% (+150bp at the mid-point) and organic revenue growth of 7.5% to 8.5%.
Copyright (c) 2025 CercleFinance.com. All rights reserved.